LTA and neoplasm: Although 2.2% of hematolymphoid malignancies were positive for MCPyV DNA, only low viral copy numbers were found, and none of the lymphoid malignancies investigated by tissue microarrays expressed the oncogenic MCPyV LT antigen in tumor cells.